News

Archive: September, 2022

Beacon of Light: NSWC Philadelphia Division Employee Awarded Armed Forces Civilian Medal for Pandemic Support
September 28, 2022 — Naval Surface Warfare Center, Philadelphia Division employee Andrew C. Lucas was awarded the Armed Forces Civilian Service Medal (AFCSM) for participating on the Joint Assisted Acquisition (JA2) program that provided the acquisition and technical expertise needed to transition and accelerate the U.S. Government’s ongoing COVID-19 response and pandemic preparedness. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s Joint Assisted Acquisition (JPEO-CBRND) JA2 team was established to serve as part of the U.S. government response, working at the forefront of ensuring that global health goals were supported, and that the international community was well-equipped to combat this pandemic... MORE

Naval Surface Warfare Center, Philadelphia Division employee Andrew C. Lucas was awarded the Armed Forces Civilian Service Medal (AFCSM) for participating on the Joint Assisted Acquisition (JA2) program

Joint Project Manager for CBRN Medical National Stock Number Sponsorship Supports Access to Critical Medical Countermeasures
September 26, 2022 — Since the beginning of the current global pandemic, the JPM CBRN Medical has played a critical role in facilitating the assignment of NSNs to relevant medical countermeasures (MCMs), resulting in increased access to protective medicines for our nation’s service members. The JPM CBRN Medical’s focus has been to identify products with supporting data from the COVID response or other approved products, which demonstrate how the product can be used as a MCM against CBRN threats... MORE

DOD Awards Follow-on Production Agreement for Rapid Opioid Countermeasure System Program Naloxone Autoinjectors
September 20, 2022 — JPM CBRN Medical awarded a follow-on Other Transaction Authority (OTA) for Production agreement to kaléo, Inc. The contract follows a previous OTA awarded to kaléo in 2019 to develop the 10mg NAI in collaboration with the JPM CBRN Medical and the Chemical and Biological Defense Program (CBDP). Under this follow-on OTA, awarded through the Army Contracting Command, kaléo will manufacture and deliver 10mg naloxone autoinjectors (NAI) as a residual capability to the DoD’s Special User Groups, as well as an emergency stockpile no later than September 2022. ... MORE

While wearing MOPP Level 4 gear a test player prepares to use a ROCS auto-injector on a simulated causality.

DOD Initiates Phase II Clinical Trial in Support of Vaccine Acceleration Program
September 12, 2022 — Dynavax, in collaboration with the JPM CBRN Medical, began a Phase II clinical trial using the JPM CBRN Medical’s Recombinant Plague (rF1V) vaccine, with Dynavax’s biological response modifier (BRM) cytosine phosphoguanine (CpG) 1018®, to help improve the vaccine’s onset of protection and efficacy level. This clinical trial will serve as a launching point to evaluate new vaccine enhancements that will help ensure vaccines are operationally relevant to the warfighter. The DOD’s Chemical and Biological Defense Program supported this effort... MORE

Rapid Opioid Countermeasure System Product Team Wins 2022 Military Health System Research Symposium Award for Outstanding Program Management Team
September 12, 2022 — JPM CBRN Medical Rapid Opioid Countermeasure System (ROCS) product team was selected to receive the 2022 MHSRS award for Outstanding Program Management (Team). This award recognizes outstanding medical product program management, highlighting team accomplishments that further mature medical research and development or commercial efforts. The ROCS team was recognized for addressing and minimizing the ROCS program’s developmental risks, managing cost, schedule, and performance, and adhering to all applicable regulatory requirements... MORE

Rapid Opioid Countermeasure System (ROCS) product team receives the 2022 MHSRS award for Outstanding Program Management (Team)

News Search

News Archive - Search by Year and Month

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.